0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover443.86%IV109.21%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.1405Delta0.0855Gamma31.87Leverage Ratio-0.0506Theta0.0001Rho4.48Eff Leverage0.0013Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet